๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Gregory Renza

Stock Analyst at Truist Financial

(4.86)
# 392
Out of 5,189 analysts
855
Total ratings
51.7%
Success rate
17%
Average return

Stocks Rated by Gregory Renza

CG Oncology
Nov 17, 2026
Reiterated: Buy
Price Target: $100
Current: $79.47
Upside: +25.83%
Perspective Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $11 → $8
Current: $0.7538
Upside: +961.29%
Agios Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $37 → $35
Current: $27.60
Upside: +26.81%
Genmab
Nov 6, 2026
Reiterated: Buy
Price Target: $67
Current: $50.60
Upside: +32.41%
MannKind
Nov 6, 2026
Reiterated: Buy
Price Target: $5
Current: $3.85
Upside: +29.87%
BeOne Medicines AG
Nov 6, 2026
Reiterated: Buy
Price Target: $420 → $448
Current: $390.94
Upside: +14.60%
Amgen
Nov 4, 2026
Reiterated: Hold
Price Target: $380 → $398
Current: $435.64
Upside: -8.64%
IDEAYA Biosciences
Nov 3, 2026
Reiterated: Buy
Price Target: $57
Current: $25.56
Upside: +123.00%
Regeneron Pharmaceuticals
Nov 2, 2026
Reiterated: Buy
Price Target: $780 → $982
Current: $920.69
Upside: +6.66%
Exelixis
Oct 30, 2026
Reiterated: Hold
Price Target: $54 → $60
Current: $64.63
Upside: -7.16%
Reiterated: Buy
Price Target: $158 → $181
Current: $166.43
Upside: +8.75%
Reiterated: Buy
Price Target: $34 → $35
Current: $26.14
Upside: +33.89%
Reiterated: Buy
Price Target: $29 → $40
Current: $33.26
Upside: +20.26%
Reiterated: Buy
Price Target: $240 → $241
Current: $161.20
Upside: +49.50%
Reiterated: Buy
Price Target: $34 → $33
Current: $12.85
Upside: +156.81%
Reiterated: Buy
Price Target: $286
Current: $230.26
Upside: +24.21%
Reiterated: Buy
Price Target: $87 → $85
Current: $24.77
Upside: +243.16%
Reiterated: Buy
Price Target: $155 → $151
Current: $73.20
Upside: +106.28%
Reiterated: Buy
Price Target: n/a
Current: $3.80
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $29.96
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $11.97
Upside: -
Reiterated: Hold
Price Target: n/a
Current: $3.69
Upside: -
Reiterated: Hold
Price Target: $7
Current: $2.90
Upside: +141.38%
Reiterated: Buy
Price Target: $26
Current: $17.11
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $1.28
Upside: n/a
Reiterated: Hold
Price Target: $5
Current: $1.76
Upside: n/a
Reiterated: Hold
Price Target: $20
Current: $2.74
Upside: n/a
Reiterated: Buy
Price Target: $16
Current: $6.33
Upside: n/a
Reiterated: Buy
Price Target: $48 → $46
Current: $8.69
Upside: n/a
Reiterated: Buy
Price Target: $16
Current: $3.82
Upside: n/a
Reiterated: Buy
Price Target: $12 → $13
Current: $5.27
Upside: n/a
Reiterated: Hold
Price Target: $38
Current: $38.00
Upside: n/a
Downgraded: Hold
Price Target: $2,160 → $180
Current: $6.76
Upside: n/a
Reiterated: Hold
Price Target: $20.41
Current: $1.62
Upside: n/a
Reiterated: Hold
Price Target: $5 → $80
Current: $0.229
Upside: n/a
Reiterated: Hold
Price Target: $1 → $15
Current: $0.000001
Upside: n/a
Rated: Buy
Price Target: $348
Current: $249.59
Upside: n/a